Pharmacognosy Research logo
Submit
Pharmacognosy ResearchACADEMIC PUBLISHING
Article

Annonacin Exerts Antitumor Activity through Induction of Apoptosis and Extracellular Signal‑regulated Kinase Inhibition

1, 1, 1, 1

  1. 1Department of Pharmacology, Faculty of Medicine, University of Malaya, MALAYSIA., 2Department of Pharmacology, UM Cancer Research Institute, Faculty of Medicine, University of Malaya, Lembah Pantai, Kuala Lumpur 50603, MALAYSIA.

CORRESPONDENCE

Ivy Chung

Department of Pharmacology, Faculty of Medicine, University of Malaya, MALAYSIA.

ivychung@ummc.edu.my

Volume 9, Issue 4 · pp. 378-383 · 2017 · DOI: 10.4103/pr.pr_19_17

ABSTRACT

Background: Endometrial cancer (EC) is the most common gynecologic malignancy in developed countries. Annonacin, a natural pure compound extracted from the seeds of Annona muricata, is a potential alternative therapeutic agent to treat EC.Objective: To study the antitumor activity of annonacin and its mechanism of action in EC cells (ECCs).Materials and Methods: Viability of ECCs treated with annonacin for 72 h was determined using methyl thiazolyl tetrazolium assay. The induction of cell cycle arrest and apoptotic cell death was evaluated using propidium iodide and annexin V‑PE/7‑AAD assay, respectively. DNA strand breaks were visualized using transferase dUTP nick end labeling assay, and the effects of annonacin on survival signaling were determined using western blotting.Results: Annonacin exhibited antiproliferative effects on EC cell lines (ECC‑1 and HEC‑1A) and primary cells (EC6‑ept and EC14‑ept) with EC50 values ranging from 4.62 to 4.92 µg/ml. EC cells were shown arrested at G2/M phase after treated with 4 µg/ml of annonacin for 72 h. This led to a significant increase in apoptotic cell death (65.7%) in these cells when compared to vehicle‑treated cells (P < 0.005). We further showed that annonacin‑mediated apoptotic cell death was associated with an increase in caspase‑3 cleavage and DNA fragmentation. Cell apoptosis was accompanied with downregulation of extracellular signal‑regulated kinase survival protein expression and induction of G2/M cell cycle arrest.Conclusion: Annonacin may be a potential novel therapeutic agent for EC patients.

KEYWORDS

Open in new tab

REFERENCES

As published

Showing references and in-text citations exactly as published.

    Cite this article

    SELECT FORMAT

    Yap, C. V., Subramaniam, K. S., Khor, S. W., & Chung, I. (2017). Annonacin Exerts Antitumor Activity through Induction of Apoptosis and Extracellular Signal‑regulated Kinase Inhibition. Pharmacognosy Research, 9(4), 378-383. https://doi.org/10.4103/pr.pr_19_17

    Copyright and licence

    © 2017 Author(s)

    This is an open access article distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 License, which allows others to remix, tweak, and build upon the work non-commercially, as long as the author is credited and the new creations are licensed under the identical terms. CC BY-NC-SA 4.0